Clínica Baviera, S.A. is a prominent European provider of ophthalmological services, operating a vast network of specialized eye clinics. The company's core business model revolves around offering advanced eye care, primarily focusing on refractive surgeries (such as LASIK and PRK to correct myopia, hyperopia, and astigmatism) and cataract surgeries, which together constitute the vast majority of its revenue. Additionally, it provides treatments for presbyopia, glaucoma, and retinal conditions. Geographically, Clínica Baviera has a strong footprint across Europe, with operations in Spain, Germany, Italy, Austria, and the United Kingdom (following its 2024 acquisition of the Optimax group). The company generates revenue primarily through fee-for-service surgical procedures and clinical consultations. Its competitive position is bolstered by its scale, specialized medical expertise, and strategic international expansion, allowing it to capture significant market share in the European private eye care sector.
